Clinical Trial Update: Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing simultaneous integrated boost to routine IMRT in limited-stage small-cell lung cancer is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Small-cell Lung Cancer | Phase 3 | Status: UNKNOWN